SCHEMBL6107273

SCHEMBL6107273

CCN(CC)CCNC(=O)c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MCHR1 Q99705 9/20 1.00
▸ ALDH1A1 P00352 1/20 0.62
▸ NFKB1 P19838 1/20 0.62
▸ KCNH2 Q12809 1/20 0.62
▸ POLB P06746 2/20 0.62
▸ CYP3A4 P08684 1/20 0.61
▸ THRB P10828 1/20 0.61
▸ BLM P54132 1/20 0.61
▸ ATM Q13315 1/20 0.61
▸ SMN1; SMN2 Q16637 1/20 0.61
▸ EPHX2 P34913 2/20 0.59
▸ TDP1 Q9NUW8 1/20 0.57
▸ HDAC3 O15379 1/20 0.54
▸ HDAC4 P56524 1/20 0.54
▸ HDAC1 Q13547 1/20 0.54
▸ HDAC7 Q8WUI4 1/20 0.54
▸ HDAC2 Q92769 1/20 0.54
▸ HDAC10 Q969S8 1/20 0.54
▸ HDAC11 Q96DB2 1/20 0.54
▸ HDAC8 Q9BY41 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6678768 0.86 MCHR1 (1.00) MCHR1ALDH1A1NFKB1KCNH2POLB
SCHEMBL2285783 0.86 MCHR1 (0.75) MCHR1ALDH1A1NFKB1KCNH2POLB
SCHEMBL6681505 0.84 MCHR1 (0.72) MCHR1ALDH1A1NFKB1KCNH2POLB
SCHEMBL6108985 0.84 MCHR1 (1.00) MCHR1
SCHEMBL8507800 0.83 MCHR1 (0.73) MCHR1ALDH1A1NFKB1KCNH2POLB
SCHEMBL6678254 0.82 MCHR1 (0.75) MCHR1ALDH1A1NFKB1KCNH2POLB
SCHEMBL6111458 0.81 MCHR1 (0.94) MCHR1
SCHEMBL20805845 0.80 EPHX2 (0.67) MCHR1EPHX2HDAC3HDAC4HDAC1
SCHEMBL12766989 0.80 POLB (0.73) MCHR1ALDH1A1NFKB1KCNH2POLB
SCHEMBL1499450 0.79 MCHR1 (0.65) MCHR1ALDH1A1EPHX2HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060235035-A1 Novel methoxybenzamibe compounds for use in mch receptor related disorders 7TM PHARMA A/S (DK) 2006-10-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060235035-A1 Novel methoxybenzamibe compounds for use in mch receptor related disorders GPR119, MCHR2, HCRTR2 MCHR1 5/4885ALDH1A1 3618/4885NFKB1 4544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback